Browsing by Subject "Drug use"

Now showing 1 - 5 of 5
  • Thumbnail Image
    Item
    Associations between Oral Health and Cannabis Use among Adolescents and Young Adults: Implications for Orthodontists
    (MDPI, 2022-11-18) Le, Austin; Khoo, Edmund; Palamar, Joseph J.; Orthodontics and Oral Facial Genetics, School of Dentistry
    Cannabis use is prevalent among adolescents and young adults in the US. Virtually all modes of cannabis consumption involve the oral cavity, and previous studies have linked cannabis use with poorer oral health. We sought to identify associations between cannabis use and various oral health outcomes and behaviors among individuals 12–25 years of age, and to discuss implications for orthodontists who largely interact with this age group over an extended period of treatment time. We examined data from patient electronic health records (N = 14,657) obtained between 2015 and 2021. Associations between lifetime and current self-reported cannabis use and several oral health outcomes or related behaviors that reflect periodontal health, caries status, oral lesions, and physical integrity of tooth structure and restorations were examined in a bivariable and multivariable manner, controlling for patient age, sex, and self-reported tobacco and alcohol use. Reporting lifetime cannabis use was associated with higher risk for having oral lesions (aPR = 1.41, 95% CI: 1.07–1.85), bruxism (aPR = 1.31, 95% CI: 1.09–1.58), and frequent consumption of sugary beverages and snacks (aPR = 1.27, 95% CI: 1.12–1.41). Reporting current cannabis use was associated with higher risk for oral lesions (aPR = 1.45, 95% CI: 1.03–2.06) and frequent consumption of sugary beverages and snacks (aPR = 1.26, 95% CI: 1.07–1.48). Cannabis users aged 12–25 are at increased risk for bruxism, oral lesions, and frequent consumption of sugary beverages and snacks. Orthodontists and other dental professionals should probe for drug use and be cognizant of increased risk for oral health problems in patients that report actively using cannabis.
  • Thumbnail Image
    Item
    Depressive Symptoms following Recent Sexual Assault: The Role of Drug and Alcohol Use, Acute Stress, and Assault Characteristics
    (SAGE Publications, 2018-10-24) Dir, Allyson L.; Hahn, Christine; Jaffe, Anna E.; Stanton, Kimberly; Gilmore, Amanda K.; Pediatrics, School of Medicine
    Sexual assault is a common traumatic experience that can have a wide-ranging impact on psychological functioning, including experience of depressive symptoms. While many studies have examined lifetime rates of depression among those with sexual assault history, less is known regarding risk factors for depressive symptoms following recent sexual assault. The study examined whether drug use history is uniquely related to depressive symptoms following recent assault. Method: N = 65 individuals (5.4% female; 73.8% white; M(SD)age = 28.89 (10.29)) who had recently experienced sexual assault (less than 60 days) and completed a SAMFE were interviewed via phone and completed questionnaires regarding depressive and acute/posttraumatic stress symptoms and substance use history. Demographic information as well as information related to the assault was also collected. Results: 68.7% of the sample reported clinically significant levels of depressive symptoms (PHQ-9 scores ≥ 12). In a linear mixed model, drug use was significantly related depressive symptoms (β = .19, p = .04), even controlling for acute/posttraumatic stress (β = .72, p < .01) and other variables. Individuals who identified as white reported more severe depressive symptoms (β = .19, p = .02). Forced sexual assault (β = −.07), victim-perpetrator relationship (β = −.01), alcohol misuse (β = −.06), and days since assault (β = −.08) were not significantly related to depressive symptoms (p’s>.05). Conclusion: Results highlight the potential role of drug use in increasing risk for experiencing clinically significant depressive symptoms following recent assault.
  • Thumbnail Image
    Item
    Housing First and harm reduction: a rapid review and document analysis of the US and Canadian open-access literature
    (BioMed Central, 2017-05-23) Watson, Dennis P.; Shuman, Valery; Kowalsky, James; Golembiewski, Elizabeth; Brown, Molly; Social and Behavioral Sciences, School of Public Health
    BACKGROUND: Housing First is an evidence-based practice intended to serve chronically homeless individuals with co-occurring serious mental illness and substance use disorders. Despite housing active substance users, harm reduction is an often-overlooked element during the Housing First implementation process in real-world settings. In this paper, we explore the representation of the Housing First model within the open-access scholarly literature as a potential contributing factor for this oversight. METHODS: We conducted a rapid review of the US and Canadian open-access Housing First literature. We followed a document analysis approach, to form an interpretation of the articles' content related to our primary research questions. RESULTS: A total of 55 articles on Housing First were included in the final analysis. Only 21 of these articles (38.1%) included explicit mention of harm reduction. Of the 34 articles that did not discuss harm reduction, 22 provided a description of the Housing First model indicating it does not require abstinence from substance use; however, descriptions did not all clearly indicate abstinence was not required beyond program entry. Additional Housing First descriptions focused on the low-barrier entry criteria and/or the intervention's client-centeredness. CONCLUSIONS: Our review demonstrated a lack of both explicit mention and informed discussion of harm reduction in the Housing First literature, which is likely contributing to the Housing First research-practice gap to some degree. Future Housing First literature should accurately explain the role of harm reduction when discussing it in the context of Housing First programming, and public agencies promoting Housing First uptake should provide resources for proper implementation and monitor program fidelity to prevent model drift.
  • Thumbnail Image
    Item
    Prenatal Substance Misuse: Exploring Healthcare Providers' Attitudes and Perceptions
    (2019-01) Trainor, Kristin Elise; Vernon, Robert; Adamek, Margaret E.; McCabe, Heather; Brann, Maria
    To maximize beneficial outcomes for babies and mothers in substance misuse situations, it is necessary to understand the current societal factors and the stigma that healthcare providers may be imposing on the families. More than 5% of all pregnancies are affected by prenatal substance misuse prompting a public health crisis. The negative effects from drug misuse on the growing baby ranges from neonatal abstinence syndrome (NAS), mental retardation, behavioral abnormalities, and neurological deficits. The exposure also causes lengthy hospitalizations for babies and high financial costs. The provider must balance their own feelings and beliefs about substance misuse in pregnancy while simultaneously providing appropriate and supportive care to the mother. However, health-related stigma can occur as providers must care for both mother and baby, in an often stressful work environment. This research explored structural stigma, which broadly encompassed the policies and cultural practices, towards women with prenatal substance misuse among providers in a maternal/fetal healthcare unit. The study, with 117 participants from an area hospital system, examined several variables including the attitudes, perceptions, and stigma among healthcare providers towards prenatal substance misuse. A factorial MANOVA and descriptive analysis was used to assess the data. Among the findings, a significant difference was found between the type of employment discipline and a practitioner’s attitudes and level of structural sigma. Direct Care Nurses had an increased negative attitude towards women with prenatal substance misuse. Additionally, there was a strong correlation (r=0.612) between the cause of substance misuse and a healthcare provider’s attitudes towards prenatal substance misuse. If the provider believed substance misuse stemmed from a moral flaw or failing, he/she had a more negative attitude towards women with prenatal substance misuse. The current study identified the potential stigma and attitudes among healthcare providers and offered insight into the practice methods within the healthcare setting. Specifically, a three-tiered protocol to improve the culture, education, and practice within the hospital setting emerged.
  • Thumbnail Image
    Item
    What can parents do? Examining the role of parental support on the negative relationship between racial discrimination, depression, and drug use among African American youth
    (Sage, 2016-07) Zapolski, Tamika C. B.; Fisher, Sycarah; Hsu, Wei-Wen; Barnes, Jessica; Psychology, School of Science
    African American youth who experience racial discrimination are at heightened risk to use drugs as a coping response to distress. Based on the buffer-stress hypothesis, we proposed that parental support would attenuate this effect. Participants were 1,521 African American youth between 4th and 12th grade. As hypothesized, a mediation pathway was observed between racial discrimination, depression symptoms, and drug use. This effect was observed for both genders, although the pathway was partially mediated for males. Additionally, as hypothesized, parental support buffered the negative effect of depression symptomatology on drug use as a consequence of discrimination. Our findings highlight the impact racial discrimination has on health outcomes for African American youth and the importance of managing youth's emotional responses to discrimination. Moreover, findings illuminate the protective role of supportive parenting within the risk model and should thus be considered as an important component within prevention programming for this population of youth.